Skip to content

Evaluation of 3D Simulation and Planning of Left Atrial Appendage Occlusion Based on 3D Echocardiography

Evaluation of 3D Simulation and Planning of Left Atrial Appendage Occlusion Based on 3D Echocardiography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05926037
Acronym
USIM-LAAO
Enrollment
30
Registered
2023-07-03
Start date
2023-09-26
Completion date
2024-11-01
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION

Brief summary

This study aims to compare a semi-automatic 3D echocardiography-based left atrial appendix occlusion procedure planning with FEops, with other imaging modalities for evaluating the left atrial appendage dimensions and device prediction (sizing, deformation) pre-left atrial appendix occlusion , including the current gold standard, CT- based FEops HEARTguideTM left atrial appendix occlusion procedure planning. A number of pre-specified endpoints are defined for analyzing this new approach.

Detailed description

First, the investigator will compare dimensions of left atrial appendix ostium and device landing zone, and the predicted device size and deformation based on the gold standard (CT-based analysis by FEops HEARTguideTM, with ostium and landing zone dimensions, predicted device size (based on the device sizing chart) and device deformation predicted by FEops analysis of the 3D echo images. Complementary, dimensions and device size prediction derived from 3D echo-derived FEops analysis, will also be compared to measurements and device size prediction obtained from pre-procedural CT images and the 2D per-procedural transesophageal echocardiographic evaluation. Secondly, the process of echo image analysis by FEops will be tested by evaluating the percentage of cases where FEops anatomical analysis is successful in providing a complete report. Based on the acquired 3D echo data, case processing is considered successful if ostium and landing zone diameters (minimum, maximum, mean and perimeter-based diameter), and device sizing, together with predicted device deformation, can be reported. The number of cases where only partial reporting is possible, as well the cases where no reporting is feasible, will also be recorded. If case analysis is not successful, the reason for failure will be reported.

Interventions

None listed

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients planned for LAAO with an Amplatzer Amulet Left Atrial Appendage Occluder (Abbott Medical) * clinical indication (in line with currently accepted indications and national reimbursement criteria) * inclusion in 2 experienced Belgian LAAO centers (Brussels and Genk)

Exclusion criteria

* contra-indication for contrast (including contrast allergy and renal failure), * contra-indication for radiation exposure (e.g. pregnancy) * Inability by FEops to analyze CT images and provide a report

Design outcomes

Primary

MeasureTime frame
Level of agreement between dimensions (minimal, maximum, mean and perimeter-based diameter of ostium and landing zone) of FEops analysis based on 3D echocar-diography vs FEops analysis based on CTDURING PROCEDURE

Secondary

MeasureTime frame
Level of agreement between predicted device deformation by analysis based on 3D echo vs FEops analysis based on CTDURING PROCEDURE
Level of agreement between dimensions (minimal, maximum, mean and perimeter-based diameter of ostium and landing zone) of FEops analysis based on 3D echo vs analysis based on 2D measurements on CT and peri-procedural echoDURING PROCEDURE
Level of agreement between predicted device size by FEops analysis based on 3D echo vs FEops analysis based on 2D measurements on CT and peri-procedural echoDURING PROCEDURE
Level of agreement between predicted device size by FEops analysis based on 3D echo vs FEops analysis based on CTDURING PROCEDURE
The percentage of 3D echocardiography cases sent to FEops, where data on ostium and landing zone diameters, and device size prediction/deformation, can only be par-tially, or are failed to be provided (descriptive)DURING PROCEDURE
Most frequent reasons for failure to provide complete reporting after FEops analysis based on 3D echo imagesDURING PROCEDURE
The percentage of 3D echocardiography cases sent to FEops, where data on ostium and landing zone diameters, and device size prediction/deformation, can successfully be provided (descriptive)DURING PROCEDURE

Countries

Belgium

Contacts

Primary ContactStijn Lochy, MD
stijn.lochy@uzbrussel.be03224776008
Backup ContactIngrid Lemoine
ingrid.lemoine@uzbrussel.be03224776008

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026